Using Mathematical Algorithms To Save Lives by Staff, Editorial
New Science
Volume 19 | Issue 1 Article 7
9-1-2011
Using Mathematical Algorithms To Save Lives
Editorial Staff
Division of Research, Wayne State University
Follow this and additional works at: http://digitalcommons.wayne.edu/newscience
This Article is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in New Science by an
authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Staff, Editorial (2011) "Using Mathematical Algorithms To Save Lives," New Science: Vol. 19: Iss. 1, Article 7.
Available at: http://digitalcommons.wayne.edu/newscience/vol19/iss1/7
N E W  S C I E N C E
Bioinformatics
Advances in molecular biology, proteomics and genetic testing have brought us closer to 
personalized health care that can tailor treatments 
to an individual patient’s needs. Data gathering 
capabilities have greatly surpassed data analysis 
techniques, creating a need for more effective 
methods to analyze a vast and growing amount of 
data. 
Bioinformatics, the use of computer science 
methods and tools in the life sciences, has 
exploded as modern high-throughput methods 
have generated a deluge of information, including 
sequence data, structural data, chemistry data, assay 
results and imaging data. While pharmaceutical and 
biotechnology companies have begun to appreciate 
the potential benefit of information technology 
systems in improving the productivity of drug 
discovery and research, several hurdles must be 
overcome to fully capitalize on the impact this data 
may have on the health care industry. 
With the help of more than $3 million in 
competitive grants from the National Institutes of 
Health (NIH) and the National Science Foundation, 
Sorin Draghici, Ph.D. is working to develop new 
and effective approaches to analyze these data 
and identify impacted gene signaling pathways 
in a given condition. Draghici holds joint 
appointments as professor in the Department of 
Computer Science, College of Engineering; and the 
departments of Clinical and Translational Science, 
and Obstetrics and Gynecology in the School of 
Medicine at Wayne State University. In recent 
years, Draghici has developed several bioinformatics 
software tools that utilize mathematical algorithms 
to extract relevant intelligence from genomics 
data by combining statistical analysis with existing 
knowledge about how these pathways work. 
Correctly identifying the significantly impacted 
gene signaling pathways in a given condition can 
lead to better decision-making capabilities for drug 
development and personalized health.
According to Draghici, current methods that 
aim to bridge the gap between data collection and 
data analysis are unsophisticated. “Many if not 
all existing methods treat the pathways as simple 
sets of genes, and either ignore or underutilize 
our current understanding about how the body’s 
systems work, as well as the gene expression 
values made available by current technologies,” he 
said. Draghici has developed bioinformatics tools 
that will lead to reliable approaches to identify 
the most impacted gene signaling pathway in a 
given condition, which ultimately will facilitate 
pinpointing the molecular causes of a given disease, 
and identifying potential therapies and possible side 
effects.
Using a systems biology approach, Draghici’s 
approach identifies pathways that are significantly 
impacted in any condition, which may be 
monitored through high-throughput gene 
expression.  His more sophisticated algorithms can 
also identify relevant signaling cascades that can be 
potentially targeted for therapeutic intervention. 
Access to these tools by biotechnology and 
pharmaceutical companies will increase efficiency in 
the drug discovery pipeline and, most importantly, 
reduce development costs of new therapeutics. Such 
tools can help organizations make early decisions 
on pursuing clinical trials.
The technology has been licensed to Advaita 
Corporation, where Draghici serves as chief 
executive officer and chief technology officer. 
Advaita has received additional funding from the 
NIH in the form of a Small Business Technology 
Transfer grant. 
Draghici’s novel analysis method can identify the 
significantly impacted gene regulatory pathways in 
a given condition, such as lung cancer, obesity and 
diabetes. Classical methods fall short and neglect to 
take into consideration the roles the genes play in 
each pathway. These classical methods can produce 
both false positives, pathways that are reported 
as being relevant when in reality they are not, as 
well as false negatives, relevant pathways that are 
not identified as being significant in the given 
condition. 
Current analysis methods rely too heavily on the 
number of differentially regulated genes that fall on 
each pathway, rather than taking into consideration 
where each gene is positioned and what each gene 
does. Draghici’s method pays close attention to 
these aspects and can potentially identify regulatory 
pathways that can open the way to new therapeutic 
interventions in a large variety of conditions such as 
cancer, pre-term labor, obesity and more, ultimately 
benefiting millions of people suffering from these 
conditions. 
“Currently, most patients with health conditions 
such as cancer are diagnosed because of a clinical 
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change, such as detecting a malignant tumor,” 
said Draghici. “By the time the tumor is found, 
treatment can be an uphill battle because of 
complex changes including the need to kill tumor 
cells that might have already spread. If a physician 
could identify a departure from the healthy state 
well before the tumor is present, these changes in 
cells may possibly be reversed. We aim to identify 
qualitative changes in the state of a biological 
system, with the ultimate goal of eradicating 
diseases not by finding a cure for them, but by 
preventing them from ever occurring in the first 
place.”  
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About Dr. Sorin Draghici:     
Dr. Draghici received a B.Sc. in 
computer engineering and an M.Sc. 
in computer science – software 
engineering from Politehnica University 
of Bucharest, Romania, and a Ph.D. 
in computer science – artificial 
intelligence from University of St. Andrews, United 
Kingdom. He joined Wayne State University in 1996. He 
was recently appointed the first Robert J. Sokol, M.D. 
Endowed Chair in Systems Biology.
To learn more, visit: 
http://vortex.cs.wayne.edu/Sorin/index.htm
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